The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects.
The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period.
All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.
Female Diagnosis of breast cancer, non-metastatic, stage 0-III (A, B, or C) Receiving or received endocrine/hormone therapy within the last 3 years (36 months) At least 18 years of age Able to speak and read English or Spanish Able to provide informed consent Self-identify Hispanic/Latina ethnicity
Exclusion Criteria:
Stage IV or metastatic Visual, hearing, voice, or motor impairment that would prevent completion of study procedures Diagnosis of an unmanaged psychotic disorder, bipolar disorder, dissociative disorder, or other diagnoses for which participation in this trial is either inappropriate or dangerous - this includes patients who have a life-threatening illness (e.g., end-stage kidney disease) or diagnosis of a chronic disease that is associated with a major functional impairment (e.g., fibromyalgia) Illicit substance or alcohol dependence Suicidal ideation, plan, intent Alzheimer's, dementia, or history of stroke Scheduled reconstruction surgery within 1 month of any study procedures or involvement.
